Home BancShares, Inc. Announces Pricing of Secondary Offering by Selling Shareholder
Sep 23, 2016 12:15 pm UTC| Business
CONWAY, Ark., Sept. 23, 2016 -- Home BancShares, Inc. (NASDAQ GS:HOMB) (the “Company”), parent company of Centennial Bank, announced today the pricing of the previously announced underwritten secondary offering of...
Gridsum Announces Pricing of Initial Public Offering
Sep 23, 2016 12:00 pm UTC| Business
BEIJING, Sept. 23, 2016 -- Gridsum Holding Inc. (“Gridsum” or the “Company”) (NASDAQ:GSUM), a leading provider of sophisticated data analysis software in China, today announced that its initial public offering of...
Apricus Biosciences Announces $4.6 Million Registered Direct Offering
Sep 23, 2016 12:00 pm UTC| Business
SAN DIEGO, Sept. 23, 2016 -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has entered into a definitive...
Catalyst Biosciences To Present at the Ladenburg Thalmann 2016 Healthcare Conference
Sep 23, 2016 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Sept. 23, 2016 -- Catalyst Biosciences, Inc. (Nasdaq:CBIO), a clinical-stage biotechnology company focused on creating and developing novel protease therapeutics to treat serious medical...
T-Mobile US, Inc. to Present at the Deutsche Bank 24th Annual Leveraged Finance Conference
Sep 23, 2016 12:00 pm UTC| Business
BELLEVUE, Wash., Sept. 23, 2016 -- J. Braxton Carter, Executive Vice President Chief Financial Officer of T-Mobile US, Inc. (NASDAQ:TMUS) will present at 8:40 a.m. Mountain Standard Time (11:40 a.m. Eastern Daylight...
Checkpoint Therapeutics to Present at the Ladenburg Thalmann 2nd Annual Healthcare Conference
Sep 23, 2016 12:00 pm UTC| Business
NEW YORK, Sept. 23, 2016 -- Checkpoint Therapeutics, Inc. (“Checkpoint”), a Fortress Biotech (NASDAQ:FBIO) company, announced today that James F. Oliviero, III, President and CEO of Checkpoint, will present at the...
Momenta Pharmaceuticals Appoints Corey N. Fishman to Board of Directors
Sep 23, 2016 12:00 pm UTC| Business
CAMBRIDGE, Mass., Sept. 23, 2016 -- Momenta Pharmaceuticals,Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced the appointment of Corey N....